Should I Buy NVS? NVS 2026 Analysis

Should You Buy Novartis AG (NVS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

148.910

1 Day change

0.70%

52 Week Range

152.480

Analysis Updated At

2026/01/26

Novartis AG (NVS) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, improving analyst sentiment, and positive technical indicators support this conclusion. While there are no immediate Intellectia trading signals, the overall outlook for the stock aligns well with a long-term investment strategy.

Technical Analysis

The technical indicators for NVS are bullish. The MACD histogram is positive and expanding, indicating upward momentum. The RSI is at 74.425, which is neutral but leaning towards overbought territory. Moving averages are in a bullish alignment (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 147.094), suggesting potential for further upward movement.

Options Data

Bearish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

The low option volume put-call ratio (0.1) indicates bullish sentiment, while the open interest put-call ratio (1.56) suggests a higher number of open put contracts, which could indicate hedging activity rather than outright bearishness.

Technical Summary

Sell

Buy

Positive Catalysts

Strong Q3 2025 financial performance with revenue up 9% YoY, net income up 23.17% YoY, and EPS up 28.66% YoY.
Positive analyst sentiment with multiple upgrades and increased price targets.
CEO's $23 billion investment deal to shield the company from U.S. pharmaceutical tariffs.
Bullish technical indicators and upward price momentum.

Neutral/Negative Catalysts

Slightly declining gross margin (-0.01% YoY).
Analysts note a 'weak' operational outlook for 2026, though this is offset by a strong pipeline.

Financial Performance

In Q3 2025, Novartis reported strong financial growth: Revenue increased by 9% YoY to $14.36 billion, net income rose by 23.17% YoY to $3.93 billion, and EPS grew by 28.66% YoY to 2.02. However, gross margin slightly declined to 75.38% (-0.01% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is improving, with multiple upgrades and increased price targets. Deutsche Bank raised its price target to CHF 125, while JPMorgan upgraded the stock to Overweight with a price target of CHF 125. Analysts highlight Novartis' strong pipeline and successful product launches, though some express concerns about operational challenges in 2026.

6 Analyst Rating

Wall Street analysts forecast NVS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NVS is 127.75 USD with a low forecast of 112 USD and a high forecast of 143 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

4 Hold

1 Sell

Hold

Current: 147.870

Low

112

Averages

127.75

High

143

Current: 147.870

Low

112

Averages

127.75

High

143

Citi

Graham Parry

Buy

initiated

CHF 133

AI Analysis

2026-01-27

New

Reason

Citi

Graham Parry

Price Target

CHF 133

AI Analysis

2026-01-27

New

initiated

Buy

Reason

Citi analyst Graham Parry initiated coverage of Novartis with a Buy rating and CHF 133 price target. The firm sees the company's earnings outperformance continuing. It believes Novartis will hit its 5%-6% annual sales growth guidance through 2030.

Deutsche Bank

Buy

maintain

2026-01-16

Reason

Deutsche Bank

Price Target

2026-01-16

maintain

Buy

Reason

Deutsche Bank raised the firm's price target on Novartis to CHF 125 from CHF 120 and keeps a Buy rating on the shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for NVS

Unlock Now

NVS Should I Buy

NVS Should I Buy

Should You Buy Novartis AG (NVS) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch